I-Mab Biopharma
IMAB
#9307
Rank
โ‚น5.71 B
Marketcap
โ‚น69.00
Share price
-5.65%
Change (1 day)
-54.04%
Change (1 year)

Revenue for I-Mab Biopharma (IMAB)

Revenue in 2024 (TTM): โ‚น0.27 Billion

According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM ) is โ‚น0.27 Billion. a decrease over the revenue in the year 2023 that were of โ‚น7.61 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for I-Mab Biopharma from 2017 to 2024

Annual revenue

Year Revenue Change
2024 N/A-100%
2023 โ‚น7.61 M-139.76%
2022-โ‚น19.15 Million-110.38%
2021โ‚น0.18 B-94.01%
2020 โ‚น3.08 B5798.4%
2019 โ‚น52.25 M-46.01%
2018 โ‚น96.78 M317.83%
2017โ‚น23.16 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น19.24 M-93.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น60.71 B 21,690.08%๐Ÿ‡บ๐Ÿ‡ธ USA